Last $66.80 USD
Change Today +2.53 / 3.94%
Volume 2.9M
STJ On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

One St. Jude Medical Drive

Saint Paul, MN 55117

United States

Phone: 651-756-2000

Fax: 651-756-3301

ferred to as a programmer. A programmer has two general functions. At the time of implant, the programmer is used to establish the initial therapeutic settings of these devices as determined by the physician. Later, the programmer is used for patient follow-up visits (which occur every 3 to 12 months based on patient need) to download stored diagnostic information from the implanted device for physicians to verify appropriate therapeutic settings. The company received FDA approval for the first software module of its Merlin Patient Care System, a universal programmer for the company’s ICDs and pacemakers. The company offers a new Pacing Systems Analyzer that integrates into the Merlin programmer to allow for testing of the leads during device implant. In addition to the programmer, physicians could monitor implanted devices and patient status using the Merlin.net Patient Care Network. This system allows daily device and patient monitoring and scheduled remote follow-ups to occur in the patient's home rather than in the physician's office. The Merlin@home line of RF transmitters (FDA and European CE Mark approvals) uses standard analog or DSL telephone lines, cellular networks, or Wi-Fi to send device and therapy data stored in devices to an Internet site for retrieval and review by the patient's physician. With the Merlin.net Patient Care Network, physicians could manage their volume of ICD and pacemaker patients by conducting remote follow-up sessions and using alerts of clinically significant events. CV The company’s CV participates in segments of the vascular and structural heart markets. Its vascular products include active vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology, vascular plugs, percutaneous catheter introducers, diagnostic guidewires, and a therapy for renal denervation. Its structural heart products include transcatheter aortic heart valves, a line of heart valve repair and replacement products and transcatheter structural heart defect devices. With its acquisition of AGA Medical Holdings, Inc., the company expanded its structural heart product portfolio with devices for left atrial appendage (LAA) closure, devices for patent foramen ovale (PFO) closure and devices to modify abnormal peripheral vessels with vascular plugs. The company offers a portfolio of access and closure devices for interventionalists. Its vascular closure devices are used to close femoral artery puncture sites following percutaneous coronary interventions (PCIs), diagnostic procedures, and certain peripheral procedures. Active or passive (manual) compression is utilized to assist in closing artery puncture sites. Its active closure devices include the company’s Angio-Seal product offering. The company’s compression assist device offerings include both the RadiStop and FemoStop compression assist devices that arrest bleeding of the radial and femoral arteries, respectively. Compression devices are used to maintain pressure on the arteriotomy in order to facilitate hemostasis. Percutaneous catheter introducers are used to create passageways for CV catheters from outside the human body through the skin into a vein, artery or other location inside the body. The company’s percutaneous catheter introducer portfolio consists primarily of peel-away and non peel-away sheaths, sheaths with and without hemostasis valves, dilators, guidewires, repositioning sleeves and needles. These products are offered in various sizes and packaging configurations. Diagnostic guidewires, such as the GuideRight and HydroSteer guidewires, are used in conjunction with percutaneous catheter introducers to aid in the introduction of intravascular catheters. Its diagnostic guidewires are available in multiple lengths and incorporate a surface finish for lasting lubricity. The company’s PressureWire Aeris and Certus guidewires provide precise measurements of intravascular pressure during a CV procedure and aids physicians in determining the beneficial lesions to treat. PressureWire Aeris is a proprietary device that transmits a pressure signal wirelessly and requires no c

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STJ:US $66.80 USD +2.53

STJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Boston Scientific Corp $12.94 USD -0.01
Coloplast A/S kr513.00 DKK +2.00
Smith & Nephew PLC 1,090 GBp +3.00
Terumo Corp ¥2,715 JPY +31.00
Zimmer Holdings Inc $110.48 USD +0.36
View Industry Companies
 

Industry Analysis

STJ

Industry Average

Valuation STJ Industry Range
Price/Earnings 22.1x
Price/Sales 3.4x
Price/Book 4.7x
Price/Cash Flow 21.7x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ST JUDE MEDICAL INC, please visit www.sjm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.